In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in ...

Improves fibrosis and steatohepatitis Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a broad clinical spectrum, ranging from simple steatosis to metabolic ...

Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

Ozempic may affect your face, bowel movements and hair. Check out the Ozempic side effects before taking this anti-diabetes ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

The ability to not just halt but potentially reverse this scarring process could transform how we approach advanced liver disease treatment. Participants receiving semaglutide experienced an ...

The study targets adults in China with overweight or obesity accompanied metabolic dysfunction-associated fatty liver disease (MAFLD ... of mazdutide versus semaglutide in Chinese adults with ...

The latest Chinese guidelines recommended GLP-1 agents such as semaglutide ... and provide a better treatment option for Chinese patients with overweight or obesity accompanied MAFLD." MAFLD is the ...